Prescription ·Strong evidence ·Reviewed May 2026
Prescription benzodiazepine (Schedule IV controlled substance) approved for generalized anxiety disorder and panic disorder. One of the most commonly prescribed benzodiazepines with rapid onset of action. Due to its relatively short half-life and high potency, alprazolam carries a higher risk of rebound anxiety and dependence compared to longer-acting benzodiazepines. Intended for short-term use. Dosage must be determined by your prescribing physician.
The bottom line
Evidence rating strong. Most-documented uses: rapid anxiety relief, panic attack reduction, acute anxiolytic effect. 11 sources indexed (1995–2024), with 9 interaction records on file.
Core mechanism
Binds to the benzodiazepine site on GABA-A receptors, enhancing the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). This increases chloride ion conductance, hyperpolarizes neuronal membranes, and reduces neuronal excitability, producing anxiolytic, sedative, muscle relaxant, and anticonvulsant effects.2,8
Rapidly absorbed. Can be taken with or without food. Do not crush, chew, or break extended-release tablets.
Valerian root has GABAergic sedative properties that can potentiate alprazolam's CNS depressant effects. The combination may cause excessive sedation, impaired motor function, respiratory depression, and increased risk of falls, particularly in elderly patients.
Recommendation: Avoid combining valerian root with alprazolam. If you use valerian for sleep, discontinue it while taking benzodiazepines. Do not drive or operate machinery if using both.
Melatonin has mild sedative properties that can add to alprazolam's CNS depressant effects. While the interaction is generally less dangerous than with kava or valerian, the combination may cause increased daytime drowsiness, dizziness, and impaired coordination.
Recommendation: Use melatonin cautiously with alprazolam. Start with a low melatonin dose (0.5-1mg). Avoid driving or operating machinery until you know how the combination affects you. Discuss timing optimization with your prescriber.
Supplemental GABA may have mild sedative and anxiolytic effects, though its ability to cross the blood-brain barrier is debated. If any GABA does reach the CNS, it could potentiate alprazolam's GABAergic effects, increasing sedation and CNS depression.
Recommendation: Use caution when combining GABA supplements with alprazolam. While oral GABA's CNS penetration is limited, the theoretical additive effect warrants monitoring for excessive sedation.
FDA Black Box Warning: Concurrent use of opioids and benzodiazepines can result in profound sedation, respiratory depression, coma, and death. This is one of the most dangerous drug-drug interactions in clinical practice.
Recommendation: Avoid concurrent prescribing whenever possible. If combined, use the lowest doses for the shortest duration. Inform patients about the risk of respiratory depression. Ensure naloxone is available.
FDA Black Box Warning: The combination of hydrocodone and alprazolam carries severe risk of fatal respiratory depression. This is among the most commonly co-prescribed dangerous drug combinations in the United States.
Recommendation: Avoid concurrent prescribing. If no alternative exists, use lowest effective doses for the shortest duration. Monitor closely for respiratory depression.
Passionflower has measurable anxiolytic and GABA-related CNS activity. Alprazolam is a benzodiazepine sedative, so the combination may cause more drowsiness, impaired coordination, slowed reaction time, or unsafe driving. Risk is higher with alcohol, opioids, sleep medicines, older age, sleep apnea, or dose escalation.
Recommendation: Avoid combining passionflower with alprazolam unless your prescriber agrees. If used, start with the lowest possible supplement dose, avoid alcohol and other sedatives, and do not drive until you know the combined effect. Seek urgent help for extreme sleepiness, confusion, falls, or slowed breathing.
Bacopa Monnieri extract inhibited CYP3A4 in vitro, and alprazolam exposure is clinically increased by CYP3A inhibition. Human data proving a Bacopa-alprazolam interaction are lacking, but the combination is plausible enough to matter because alprazolam has dose-related sedation and impairment. Risk is higher with high-dose Bacopa products, older age, liver disease, alcohol, opioids, or other sedatives.
Recommendation: Use extra caution when starting Bacopa Monnieri if you take alprazolam. Avoid alcohol and other sedatives, and watch for stronger or longer alprazolam effects such as unusual drowsiness, confusion, poor coordination, or memory problems. Ask your prescriber whether alprazolam dose timing or dose should be adjusted if symptoms increase.
Alcohol can sharply amplify alprazolam's sedating and coordination-impairing effects. The combination increases risk of blackouts, falls, motor vehicle crashes, respiratory depression, and accidental overdose. Risk is highest with higher alprazolam doses, older age, sleep apnea, lung disease, or any additional sedating medication.
Recommendation: Do not drink alcohol while taking alprazolam. If you drank recently, avoid non-urgent alprazolam dosing and ask your prescriber or pharmacist for individualized guidance. Seek urgent help for extreme sleepiness, slow breathing, confusion, or inability to wake.
St. John's Wort can induce CYP3A4, the main enzyme clearing alprazolam. High-hyperforin St. John's Wort products may lower alprazolam exposure and reduce anxiety control; stopping the herb can then allow alprazolam levels to rise again. Low-hyperforin products may have little effect, so product variability is a major issue.
Recommendation: Avoid starting or stopping St. John's Wort while taking alprazolam unless your prescriber is managing the change. Do not increase alprazolam on your own if anxiety worsens after starting the herb. Watch for oversedation if St. John's Wort is stopped after an alprazolam dose increase.
Numbered references. Citations throughout the page link here.
Cochrane network meta-analysis found alprazolam among the most effective pharmacological treatments for panic disorder, with significantly better response than placebo; SSRIs and SNRIs also effective but alprazolam showed faster onset of action.
Network meta-analysis of 89 studies found benzodiazepines including alprazolam effective for GAD but noted concerns about dependence, withdrawal, and inferior long-term outcomes compared to antidepressants.
Srisurapanont M, Boonyanaruthee V. Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 1997
Jonas JM, Hearron AE Jr. Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. Journal of clinical psychopharmacology. 1996
Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International clinical psychopharmacology. 1995
Huang F, San X, Liu Q et al.. Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database. Scientific reports. 2024
Kelty E, Chitty K, Preen DB. Safety of Alprazolam Use in Pregnancy in Western Australia: A Retrospective Cohort Study Using Linked Health Data. Journal of psychoactive drugs. 2024
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack